Apollo Hospitals Chennai is a leading destination for heart transplants, particularly for patients with advanced heart failure.
Behind every successful heart transplant at Apollo is a team of dedicated professionals whose sole aim is to give patients a new lease on life. This includes:
Heart transplantation isn't a procedure that's recommended off the bat. It's typically reserved for those who have exhausted other treatment options without significant improvement. The major indications for a heart transplant include:
Before even considering a heart transplant, potential recipients undergo a thorough medical evaluation. This assessment determines if they are suitable candidates based on their overall health, other medical conditions, and their ability to adhere to post-transplant medications and follow-ups.
Once deemed suitable, the patient is placed on a waiting list for a donor heart. The wait can vary from days to several months or even longer. The matching process considers blood type, body size, medical urgency, and how long the patient has been on the waiting list.
When a potential donor heart becomes available, the transplant team contacts the recipient. The patient is instructed to come to the hospital immediately, as time is of the essence.
Apollo boasts of an impressive long-term survival rate for heart transplants at 89.3% and for lungs at 73%.
Upon arrival at the hospital, the patient undergoes final tests to ensure they are still a suitable candidate for the transplant. At the same time, the donor heart is evaluated to ensure it's healthy and a good match.
After the surgery, the patient is taken to the intensive care unit (ICU) for close monitoring. They are usually on a ventilator to help them breathe. As they stabilize, they are moved to a regular room and eventually start physical therapy to regain strength.
Post-transplant, patients are advised to adopt a heart-healthy lifestyle. This includes a balanced diet, regular exercise, avoiding smoking and excessive alcohol, and managing stress.
Post-transplant, patients undergo regular check-ups to monitor heart function, detect early signs of rejection, and adjust medications accordingly in Apollo Chennai.
Apollo's specialized program for primary pulmonary hypertension and interstitial lung disease has achieved success rates of 80% and 71% respectively.
Apollo Chennai has several firsts to its credit, including:
Innovative Techniques: The team introduced the Optical Coherence Tomogram (OCT) for assessing chronic rejection in patients over 4 years post-transplant, a technique that's still evolving in the West.
Recognition on the Global Stage: The International Society for Heart and Lung Transplant (ISHLT) based in the US has recognized Apollo's excellence by admitting it as the first unit in India to participate in their registry. This not only ensures international scrutiny and transparency but also showcases Apollo's outcomes against top international centers.